Total Payments
$5,234
2024 Payments
$533.56
Companies
33
Transactions
304
Medicare Patients
3,770
Medicare Billing
$429,924
Payment Breakdown by Category
Food & Beverage$5,082 (97.1%)
Other$152.06 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,082 | 302 | 97.1% |
| Grant | $142.86 | 1 | 2.7% |
| Entertainment | $9.20 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $792.60 | 53 | $0 (2024) |
| ABBVIE INC. | $655.66 | 39 | $0 (2024) |
| Allergan, Inc. | $487.07 | 27 | $0 (2020) |
| PFIZER INC. | $461.24 | 28 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $343.97 | 20 | $0 (2022) |
| Janssen Biotech, Inc. | $302.77 | 18 | $0 (2020) |
| Intercept Pharmaceuticals, Inc. | $245.11 | 15 | $0 (2024) |
| Braintree Laboratories, Inc. | $238.13 | 7 | $0 (2022) |
| Gilead Sciences, Inc. | $231.59 | 13 | $0 (2023) |
| UCB, Inc. | $180.63 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $533.56 | 24 | ABBVIE INC. ($170.14) |
| 2023 | $390.14 | 20 | AbbVie Inc. ($135.89) |
| 2022 | $281.05 | 14 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($138.00) |
| 2021 | $255.52 | 15 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($146.32) |
| 2020 | $563.35 | 39 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($272.73) |
| 2019 | $1,141 | 63 | PFIZER INC. ($282.21) |
| 2018 | $1,133 | 68 | Allergan Inc. ($313.30) |
| 2017 | $936.30 | 61 | AbbVie, Inc. ($152.16) |
All Payment Transactions
304 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/11/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 12/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Immunology | ||||||
| 11/27/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/06/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 10/31/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 08/15/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 07/30/2024 | Boston Scientific Corporation | Resolution 360 Clip (Device) | Food and Beverage | In-kind items and services | $31.91 | General |
| Category: Resolution 360 Clip_ENDO | ||||||
| 07/23/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 06/28/2024 | Boston Scientific Corporation | CRE PRO (Device) | Food and Beverage | In-kind items and services | $36.10 | General |
| Category: CRE_ENDO | ||||||
| 06/20/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 05/24/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/15/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.88 | General |
| Category: Neuroscience | ||||||
| 05/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Gastroenterology | ||||||
| 03/27/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Urology | ||||||
| 03/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.67 | General |
| Category: Immunology | ||||||
| 03/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: IMMUNOLOGY | ||||||
| 03/18/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $30.76 | General |
| Category: VIROLOGY | ||||||
| 03/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: IMMUNOLOGY | ||||||
| 03/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: IMMUNOLOGY | ||||||
| 03/02/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: VIROLOGY | ||||||
| 02/27/2024 | Micro-tech Endoscopy USA, Inc. | LesionHunter (Device) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: GI Endoscopy | ||||||
| 02/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: IMMUNOLOGY | ||||||
| 01/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 915 | 1,028 | $517,371 | $107,432 |
| 2022 | 19 | 1,102 | 1,279 | $487,302 | $114,093 |
| 2021 | 16 | 987 | 1,176 | $512,303 | $117,292 |
| 2020 | 18 | 766 | 858 | $379,556 | $91,107 |
Total Patients
3,770
Total Services
4,341
Medicare Billing
$429,924
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 120 | $41,160 | $12,071 | 29.3% |
| 43237 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | Facility | 2023 | 74 | 74 | $48,618 | $11,893 | 24.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 162 | 166 | $102,920 | $11,234 | 10.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 57 | 61 | $39,467 | $8,951 | 22.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 43 | 43 | $36,808 | $8,796 | 23.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 63 | 67 | $41,808 | $8,244 | 19.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 35 | 35 | $43,330 | $6,877 | 15.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 31 | 63 | $20,853 | $6,166 | 29.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 47 | 47 | $36,425 | $5,758 | 15.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $22,704 | $5,457 | 24.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 27 | 27 | $16,875 | $5,318 | 31.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 67 | $15,343 | $4,486 | 29.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 46 | 46 | $16,008 | $3,997 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 46 | $10,626 | $3,503 | 33.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $12,000 | $1,879 | 15.7% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 33 | 35 | $5,425 | $1,721 | 31.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 35 | 39 | $2,496 | $554.17 | 22.2% |
| 43450 | Dilation of esophagus | Facility | 2023 | 11 | 11 | $4,235 | $377.19 | 8.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 16 | 18 | $270.00 | $151.20 | 56.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 80 | 82 | $53,054 | $13,960 | 26.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 45 | 46 | $39,376 | $10,303 | 26.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 71 | 162 | $37,098 | $9,952 | 26.8% |
| 43237 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | Facility | 2022 | 57 | 57 | $37,449 | $9,832 | 26.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 164 | 189 | $29,295 | $9,526 | 32.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 63 | 63 | $39,312 | $9,260 | 23.6% |
About Dr. Arthur Walczyk, MD
Dr. Arthur Walczyk, MD is a Gastroenterology healthcare provider based in Poughkeepsie, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1003800723.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arthur Walczyk, MD has received a total of $5,234 in payments from pharmaceutical and medical device companies, with $533.56 received in 2024. These payments were reported across 304 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,082).
As a Medicare-enrolled provider, Walczyk has provided services to 3,770 Medicare beneficiaries, totaling 4,341 services with total Medicare billing of $429,924. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Poughkeepsie, NY
- Active Since 09/08/2005
- Last Updated 07/21/2022
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1003800723
Products in Payments
- XIFAXAN (Drug) $502.75
- STELARA (Biological) $302.77
- XELJANZ (Drug) $247.78
- TRULANCE (Drug) $239.21
- Entyvio (Biological) $233.88
- LINZESS (Drug) $219.30
- INFLECTRA (Biological) $213.46
- DUPIXENT (Biological) $196.87
- OCALIVA (Drug) $193.34
- RINVOQ (Biological) $185.01
- Cimzia (Drug) $180.63
- VIBERZI (Drug) $177.59
- ZENPEP (Drug) $164.98
- CLENPIQ (Drug) $147.55
- SUPREP BOWEL PREP (Drug) $142.86
- Humira (Biological) $138.55
- Trulance (Drug) $122.89
- Amitiza (Drug) $111.68
- Mavyret (Drug) $100.72
- NASCOBAL (Drug) $81.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Poughkeepsie
Anthony Starpoli, M.d, M.D
Gastroenterology — Payments: $47,720
Gastroenterology $47,720
Dr. Robert Dean, Md, MD
Gastroenterology — Payments: $37,658
Gastroenterology $37,658
Dr. Peter Varunok, Md, MD
Gastroenterology — Payments: $35,234
Gastroenterology $35,234
Ravi Hotchandani, Md, MD
Gastroenterology — Payments: $28,261
Gastroenterology $28,261
Dr. Salvatore Buffa, Md, MD
Gastroenterology — Payments: $13,778
Gastroenterology $13,778
Dr. Farah Toyserkani, Md, MD
Gastroenterology — Payments: $10,977
Gastroenterology $10,977